Exhaled breath condensate in patients with asthma: Implications for application in clinical practice

Clinical and Experimental Allergy

Volumn 38, Issue 4, 2008, Pages 557-565

  Kostikas, K ^a   Koutsokera, A ^a   Papiris, S ^b   Gourgoulianis, K I ^a   Loukides, S ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALDEHYDE; AMMONIA; ANTIASTHMATIC AGENT; BECLOMETASONE; BIOLOGICAL MARKER; CORTICOSTEROID; CYTOKINE; HYDROGEN PEROXIDE; ICOSANOID; ISOPROSTANE DERIVATIVE; LEUKOTRIENE DERIVATIVE; MONTELUKAST; NEW ZEALAND GREEN LIPPED MUSSEL EXTRACT; NITROGEN OXIDE; PEPTIDE; PROSTANOID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ASTHMA; CLINICAL PRACTICE; DISEASE SEVERITY; EOSINOPHIL; EXHALED BREATH CONDENSATE; HUMAN; NON INVASIVE PROCEDURE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PH; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; REVIEW; SPUTUM;

ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CLINICAL TRIALS AS TOPIC; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 40949087683     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.02940.x     Document Type: Review

References (106)

1. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991 181 : 852 7.
2. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994 343 : 133 5.
3. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001 163 : 1693 722.
4. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005 352 : 2163 73.
5. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006 130 : 1541 6.
6. Brightling CE. Clinical applications of induced sputum. Chest 2006 129 : 1344 8.
7. Nightingale JA, Rogers DF, Barnes PJ. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax 1998 53 : 87 90.
8. Green RH, Brightling CE, McKenna S et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002 360 : 1715 21.
9. Fahy JV, Boushey HA, Lazarus SC et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001 163 : 1470 5.
10. Montuschi P. Indirect monitoring of lung inflammation. Nat Rev Drug Discov 2002 1 : 238 42.
11. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002 110 : 28 34.
12. Montuschi P. New perspectives in monitoring lung inflammation: analysis of exhaled breath condensate. Boca Raton, FL : CRC Press, 2005.
13. Horvath I, Hunt J, Barnes PJ et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005 26 : 523 48.
14. Montuschi P. Exhaled breath condensate analysis in patients with COPD. Clin Chim Acta 2005 356 : 22 34.
15. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002 165 : 1364 70.
16. Hunt JF, Fang K, Malik R et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000 161 : 694 9.
17. Barnes PJ. Reactive oxygen species and airway inflammation. Free Radic Biol Med 1990 9 : 235 43.
18. 2 and 3,3′,5,5′-tetramethylbenzidine]. J Clin Chem Clin Biochem 1985 23 : 453 60.
19. Dekhuijzen PN, Aben KK, Dekker I et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996 154 : 813 6.
20. Hyslop PA, Sklar LA. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation processes. Anal Biochem 1984 141 : 280 6.
21. 2 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. J Immunol Methods 1983 63 : 347 57.
22. Nowak D, Kalucka S, Bialasiewicz P, Krol M. Exhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001 30 : 178 86.
23. Gerritsen WB, Zanen P, Bauwens AA, van den Bosch JM, Haas FJ. Validation of a new method to measure hydrogen peroxide in exhaled breath condensate. Respir Med 2005 99 : 1132 7.
24. Antczak A, Nowak D, Shariati B, Krol M, Piasecka G, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997 10 : 1235 41.
25. Emelyanov A, Fedoseev G, Abulimity A et al. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 2001 120 : 1136 9.
26. Ganas K, Loukides S, Papatheodorou G, Panagou P, Kalogeropoulos N. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 2001 95 : 649 54.
27. Horvath I, Donnelly LE, Kiss A et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998 158 : 1042 6.
28. Loukides S, Bouros D, Papatheodorou G, Panagou P, Siafakas NM. The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 2002 121 : 338 46.
29. Antczak A, Kurmanowska Z, Kasielski M, Nowak D. Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients. Respir Med 2000 94 : 416 21.
30. Hulsmann AR, Raatgeep HR, den Hollander JC et al. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med 1994 149 : 519 25.
31. Emelyanov A, Fedoseev G, Krasnoschekova O, Abulimity A, Trendeleva T, Barnes PJ. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002 20 : 596 600.
32. Sandrini A, Ferreira IM, Gutierrez C, Jardim JR, Zamel N, Chapman KR. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 2003 124 : 1334 40.
33. Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR. Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 2003 111 : 313 20.
34. Morrow JD, Roberts LJ II. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996 51 : 1 9.
35. Montuschi P, Barnes P, Roberts LJ II. Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007 14 : 703 17.
36. Montuschi P, Barnes PJ, Roberts LJ II. Isoprostanes: markers and mediators of oxidative stress. Faseb J 2004 18 : 1791 800.
37. Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005 10 (Suppl. 1) : S10 23.
38. Montuschi P, Barnes PJ. Isoprostanes and asthma. Drug Discov Today: Therapeutic Strategies 2006 3 : 287 92.
39. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999 160 : 216 20.
40. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ. Exhaled 8-isoprostane in childhood asthma. Respir Res 2005 6 : 79.
41. Antczak A, Montuschi P, Kharitonov S, Gorski P, Barnes PJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002 166 : 301 6.
42. Baraldi E, Carraro S, Alinovi R et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003 58 : 505 9.
43. Battaglia S, den Hertog H, Timmers MC et al. Small airways function and molecular markers in exhaled air in mild asthma. Thorax 2005 60 : 639 44.
44. Shimizu Y, Dobashi K, Zhao JJ et al. Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease. Respiration 2007 74 : 558 64.
45. Corradi M, Folesani G, Andreoli R et al. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med 2003 167 : 395 9.
46. Corradi M, Pignatti P, Manini P et al. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Respir J 2004 24 : 1011 7.
47. Eiserich JP, Patel RP, O'Donnell VB. Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 1998 19 : 221 357.
48. Ricciardolo FL, Di Stefano A, Sabatini F, Folkerts G. Reactive nitrogen species in the respiratory tract. Eur J Pharmacol 2006 533 : 240 52.
49. Tsikas D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res 2005 39 : 797 815.
50. Ratnawati R, Morton J, Henry RL, Thomas PS. Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol 2006 41 : 929 36.
51. Corradi M, Pesci A, Casana R et al. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide 2003 8 : 26 30.
52. McSharry CP, McKay IC, Chaudhuri R, Livingston E, Fraser I, Thomson NC. Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma. J Allergy Clin Immunol 2005 116 : 88 93.
53. Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000 162 : 1273 6.
54. Baraldi E, Giordano G, Pasquale MF et al. 3-Nitrotyrosine, a marker of nitrosative stress, is increased in breath condensate of allergic asthmatic children. Allergy 2006 61 : 90 6.
55. Bodini A, Peroni DG, Zardini F et al. Flunisolide decreases exhaled nitric oxide and nitrotyrosine levels in asthmatic children. Mediators Inflamm 2006 2006 : 31919.
56. Eu JP, Liu L, Zeng M, Stamler JS. An apoptotic model for nitrosative stress. Biochemistry 2000 39 : 1040 7.
57. Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006 533 : 222 39.
58. Corradi M, Montuschi P, Donnelly LE, Pesci A, Kharitonov SA, Barnes PJ. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 2001 163 : 854 8.
59. Folco G, Murphy RC. Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacol Rev 2006 58 : 375 88.
60. Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 2006 119 : 229 40.
61. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001 294 : 1871 5.
62. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Prostaglandin E2 in the expired breath condensate of patients with asthma. Eur Respir J 2003 22 : 743 7.
63. Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002 109 : 615 20.
64. Montuschi P, Ragazzoni E, Valente S et al. Validation of 8-isoprostane and prostaglandin E(2) measurements in exhaled breath condensate. Inflamm Res 2003 52 : 502 7.
65. Huszar E, Szabo Z, Jakab A, Barta I, Herjavecz I, Horvath I. Comparative measurement of thromboxane A2 metabolites in exhaled breath condensate by different immunoassays. Inflamm Res 2005 54 : 350 5.
66. Baraldi E, Ghiro L, Piovan V et al. Increased exhaled 8-isoprostane in childhood asthma. Chest 2003 124 : 25 31.
67. Mondino C, Ciabattoni G, Koch P et al. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol 2004 114 : 761 7.
68. Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol 2006 118 : 347 53.
69. Sanak M, Kielbasa B, Bochenek G, Szczeklik A. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin Exp Allergy 2004 34 : 1899 904.
70. Wenzel SE. The role of leukotrienes in asthma. Prostaglandins Leukot Essent Fatty Acids 2003 69 : 145 55.
71. Montuschi P, Sala A, Dahlen SE, Folco G. Pharmacological modulation of the leukotriene pathway in allergic airway disease. Drug Discov Today 2007 12 : 404 12.
72. Cap P, Chladek J, Pehal F et al. Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients. Thorax 2004 59 : 465 70.
73. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002 166 : 1345 9.
74. Zanconato S, Carraro S, Corradi M et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004 113 : 257 63.
75. Failla M, Biondi G, Provvidenza Pistorio M et al. Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients. Clin Exp Allergy 2006 36 : 325 30.
76. Carraro S, Corradi M, Zanconato S et al. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005 115 : 764 70.
77. Bucchioni E, Csoma Z, Allegra L, Chung KF, Barnes PJ, Kharitonov SA. Adenosine 5′-monophosphate increases levels of leukotrienes in breath condensate in asthma. Respir Med 2004 98 : 651 5.
78. Shibata A, Katsunuma T, Tomikawa M et al. Increased leukotriene E4 in the exhaled breath condensate of children with mild asthma. Chest 2006 130 : 1718 22.
79. Lex C, Zacharasiewicz A, Payne DN et al. Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study. Respir Res 2006 7 : 63.
80. Biernacki WA, Kharitonov SA, Biernacka HM, Barnes PJ. Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients. Chest 2005 128 : 1958 63.
81. Bodini A, Peroni D, Vicentini L et al. Exhaled breath condensate eicosanoids and sputum eosinophils in asthmatic children: a pilot study. Pediatr Allergy Immunol 2004 15 : 26 31.
82. Montuschi P, Martello S, Felli M, Mondino C, Barnes PJ, Chiarotti M. Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children. Respir Res 2005 6 : 119.
83. Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005 127 : 1553 9.
84. Montuschi P, Kharitonov SA, Ciabattoni G, Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003 58 : 585 8.
85. Vaughan J, Ngamtrakulpanit L, Pajewski TN et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003 22 : 889 94.
86. Paget-Brown AO, Ngamtrakulpanit L, Smith A et al. Normative data for pH of exhaled breath condensate. Chest 2006 129 : 426 30.
87. 2 partial pressure. Eur Respir J 2007 29 : 496 501.
88. Effros RM, Casaburi R, Su J et al. The effects of volatile salivary acids and bases on exhaled breath condensate pH. Am J Respir Crit Care Med 2006 173 : 386 92.
89. Wells K, Vaughan J, Pajewski TN et al. Exhaled breath condensate pH assays are not influenced by oral ammonia. Thorax 2005 60 : 27 31.
90. Effros RM. Do low exhaled condensate NH4+concentrations in asthma reflect reduced pulmonary production? Am J Respir Crit Care Med 2003 167 : 91 author reply 91-2.
91. Prieto L, Ferrer A, Palop J, Domenech J, Llusar R, Rojas R. Differences in exhaled breath condensate pH measurements between samples obtained with two commercial devices. Respir Med 2007 101 : 1715 20.
92. Leung TF, Li CY, Yung E, Liu EK, Lam CW, Wong GW. Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate. Pediatr Pulmonol 2006 41 : 87 94.
93. Boulet LP, Lemiere C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest 2006 129 : 661 8.
94. Brunetti L, Francavilla R, Tesse R et al. Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis. Pediatr Allergy Immunol 2006 17 : 422 7.
95. Nicolaou NC, Lowe LA, Murray CS, Woodcock A, Simpson A, Custovic A. Exhaled breath condensate pH and childhood asthma: unselected birth cohort study. Am J Respir Crit Care Med 2006 174 : 254 9.
96. Hunt JF, Erwin E, Palmer L et al. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J Respir Crit Care Med 2002 165 : 101 7.
97. Carraro S, Doherty J, Zaman K et al. S-nitrosothiols regulate cell-surface pH buffering by airway epithelial cells during the human immune response to rhinovirus. Am J Physiol Lung Cell Mol Physiol 2006 290 : L827 32.
98. Gaston B, Kelly R, Urban P et al. Buffering airway acid decreases exhaled nitric oxide in asthma. J Allergy Clin Immunol 2006 118 : 817 22.
99. Matsunaga K, Yanagisawa S, Ichikawa T et al. Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients. J Allergy Clin Immunol 2006 118 : 84 90.
100. Robroeks CM, Jobsis Q, Damoiseaux JG et al. Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis. Ann Allergy Asthma Immunol 2006 96 : 349 55.
101. Ko FW, Lau CY, Leung TF et al. Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients. Clin Exp Allergy 2006 36 : 44 51.
102. Csoma Z, Huszar E, Vizi E et al. Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur Respir J 2005 25 : 873 8.
103. Vass G, Huszar E, Augusztinovicz M et al. The effect of allergic rhinitis on adenosine concentration in exhaled breath condensate. Clin Exp Allergy 2006 36 : 742 7.
104. Mutti A, Corradi M, Goldoni M, Vettori MV, Bernard A, Apostoli P. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest 2006 129 : 1288 97.
105. Carraro S, Rezzi S, Reniero F et al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007 175 : 986 90.
106. Montuschi P, Martello S, Felli M, Mondino C, Chiarotti M. Ion trap liquid chromatography/tandem mass spectrometry analysis of leukotriene B4 in exhaled breath condensate. Rapid Commun Mass Spectrom 2004 18 : 2723 9.